Second, cancer staging data were unavailable for a significant portion of the cohort, precluding stratified analyses based on disease stage—an important omission given that tumor-induced ADH secretion or organ compromise may alter hyponatremia risk. The gene discussed is AVP; the disease is Hyponatremia.